Scarica l'app Stockscreener
0.5049
5.06%
-0.0269
Precedente Chiudi:
$0.5318
Aprire:
$0.53
Volume 24 ore:
4.98M
Relative Volume:
0.90
Capitalizzazione di mercato:
$152.33M
Reddito:
$52.29M
Utile/perdita netta:
$-134.84M
Rapporto P/E:
-0.6732
EPS:
-0.75
Flusso di cassa netto:
$-117.11M
1 W Prestazione:
-7.73%
1M Prestazione:
-2.43%
6M Prestazione:
-49.32%
1 anno Prestazione:
-37.71%
Intervallo 1D:
$0.5015
$0.532
Intervallo di 1 settimana:
$0.5015
$0.56
Portata 52W:
$0.4111
$3.179
Sangamo Therapeutics Inc Stock (SGMO) Company Profile
Nome
Sangamo Therapeutics Inc
Settore
Industria
Telefono
(510) 970-6000
Indirizzo
501 CANAL BLVD., RICHMOND, CA
Confronta SGMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGMO
Sangamo Therapeutics Inc
|
0.5049 | 160.45M | 52.29M | -134.84M | -117.11M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-13 | Aggiornamento | Truist | Hold → Buy |
| 2024-12-10 | Reiterato | H.C. Wainwright | Buy |
| 2023-11-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-04-28 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-02-27 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-01-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-06-13 | Ripresa | Wedbush | Neutral |
| 2021-05-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-01-07 | Ripresa | Guggenheim | Neutral |
| 2021-01-06 | Iniziato | Stifel | Hold |
| 2020-12-16 | Ripresa | H.C. Wainwright | Buy |
| 2020-09-08 | Iniziato | BofA Securities | Buy |
| 2020-07-07 | Iniziato | SunTrust | Buy |
| 2019-08-26 | Iniziato | H.C. Wainwright | Buy |
| 2018-11-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-11-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2018-10-10 | Iniziato | Guggenheim | Buy |
| 2018-06-20 | Iniziato | BofA/Merrill | Buy |
| 2017-11-15 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2016-11-01 | Downgrade | Wedbush | Outperform → Neutral |
| 2016-10-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2015-12-04 | Iniziato | Wells Fargo | Outperform |
| 2015-10-23 | Ripresa | Jefferies | Buy |
| 2013-05-03 | Iniziato | BioLogic Equity Research | Sell |
| 2011-02-23 | Reiterato | JMP Securities | Mkt Outperform |
| 2010-07-29 | Reiterato | Wedbush | Outperform |
| 2009-10-19 | Iniziato | Brean Murray | Sell |
| 2009-10-07 | Reiterato | Leerink Swann | Outperform |
| 2009-08-25 | Reiterato | JMP Securities | Mkt Outperform |
Mostra tutto
Sangamo Therapeutics Inc Borsa (SGMO) Ultime notizie
Sangamo Therapeutics falls on CFO retirement - MSN
Sangamo Therapeutics CFO Prathyusha Duraibabu to Step Down - MarketScreener
Sangamo Therapeutics falls on CFO retirement (SGMO:NASDAQ) - Seeking Alpha
Sangamo Biosciences CFO Resignation Announced - MSN
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Sangamo Therapeutics CFO Prathyusha Duraibabu resignedSEC filing - MarketScreener
What dividend growth rate does Sangamo Therapeutics Inc. offerPortfolio Performance Summary & Real-Time Stock Price Movement Reports - Lancaster City Council
Earnings Miss: Does Sangamo Therapeutics Inc. have pricing powerTrade Analysis Summary & AI Enhanced Trade Execution Alerts - Lancaster City Council
Sangamo presents epigenetic therapy for small fiber neuropathy - BioWorld MedTech
Sangamo Therapeutics Inc. Attempts Reversal From Key SupportJuly 2025 Summary & Safe Entry Momentum Stock Tips - beatles.ru
Evaluating Sangamo Therapeutics Inc. with trendline analysisJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - Newser
Is Sangamo Therapeutics Inc. undervalued by DCF analysisGlobal Markets & Weekly High Return Opportunities - خودرو بانک
Will Sangamo Therapeutics Inc. benefit from current market trends2025 Market Outlook & AI Based Buy and Sell Signals - خودرو بانک
Comparing Sangamo Therapeutics Inc. in custom built stock radarsJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - Newser
Can Sangamo Therapeutics Inc. stock outperform in a bear marketProfit Target & Long-Term Safe Investment Plans - خودرو بانک
Sangamo reports promising data for Fabry disease gene therapy By Investing.com - Investing.com Canada
Custom strategy builders for tracking Sangamo Therapeutics Inc.July 2025 Drop Watch & Low Drawdown Trading Techniques - Newser
Is Sangamo Therapeutics Inc. benefiting from interest rate changesPortfolio Value Report & Real-Time Market Sentiment Reports - خودرو بانک
Risk adjusted return profile for Sangamo Therapeutics Inc. analyzedJuly 2025 Opening Moves & Stock Market Timing Techniques - Newser
Sangamo Therapeutics: A High-Conviction Biotech Play with a Clear Path to FDA Approval in 2026 - AInvest
Sangamo reports promising data for Fabry disease gene therapy - Investing.com
Sangamo Biosciences Reveals Promising Fabry Disease Study Results - TipRanks
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025 - The Manila Times
1.97 mL/min Kidney Function Improvement: Sangamo's One-Time Gene Therapy Could Transform Fabry Disease Care - Stock Titan
Will Sangamo Therapeutics Inc. stock recover after recent dropJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Chart based analysis of Sangamo Therapeutics Inc. trendsJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
Published on: 2025-09-04 02:16:59 - Newser
Will Sangamo Therapeutics Inc. outperform its industry peers2025 Price Momentum & Free Expert Verified Stock Movement Alerts - خودرو بانک
Measuring Sangamo Therapeutics Inc.’s beta against major indices2025 Price Action Summary & Step-by-Step Swing Trade Plans - Newser
What the charts say about Sangamo Therapeutics Inc. todayFed Meeting & Low Drawdown Trading Techniques - Newser
What are Sangamo Therapeutics Inc.’s recent SEC filings showingJuly 2025 Big Picture & Short-Term High Return Strategies - خودرو بانک
Smart tools for monitoring Sangamo Therapeutics Inc.’s price actionEarnings Overview Summary & Smart Money Movement Alerts - Newser
What’s the profit margin of Sangamo Therapeutics Inc.July 2025 Summary & Risk Adjusted Buy and Sell Alerts - خودرو بانک
What MACD signals say about Sangamo Therapeutics Inc.Rate Hike & Fast Momentum Stock Entry Tips - Newser
What institutional flow reveals about Sangamo Therapeutics Inc.Bull Run & Weekly High Potential Stock Alerts - Newser
Analyzing Sangamo Therapeutics Inc. with risk reward ratio charts2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Real time breakdown of Sangamo Therapeutics Inc. stock performance2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Should I buy Sangamo Therapeutics Inc. stock now2025 Biggest Moves & Daily Growth Stock Investment Tips - خودرو بانک
Sangamo Therapeutics Inc.’s volatility index tracking explainedTrade Volume Report & Short-Term Trading Opportunity Alerts - Newser
Is Sangamo Therapeutics Inc.’s ROE strong enough2025 Growth vs Value & Weekly Breakout Watchlists - خودرو بانک
Should you hold or exit Sangamo Therapeutics Inc. nowLayoff News & Risk Controlled Stock Pick Alerts - Newser
Sangamo Therapeutics Inc. stock trend outlook and recovery pathEarnings Growth Summary & Real-Time Chart Breakout Alerts - Newser
Technical analysis overview for Sangamo Therapeutics Inc. stock2025 Stock Rankings & Consistent Profit Alerts - Newser
Will Sangamo Therapeutics Inc. bounce back from current support2025 Volatility Report & Precise Swing Trade Entry Alerts - Newser
Is Sangamo Therapeutics Inc. benefiting from innovation trendsJuly 2025 Patterns & Fast Exit and Entry Trade Guides - خودرو بانک
Is Sangamo Therapeutics Inc. a cyclical or defensive stockPortfolio Profit Report & Community Verified Watchlist Alerts - خودرو بانک
CEO Moves: Should I buy Sangamo Therapeutics Inc. stock now2025 Risk Factors & Weekly Stock Breakout Alerts - خودرو بانک
Does Sangamo Therapeutics Inc. fit your quant trading modelWeekly Trade Report & Weekly Hot Stock Watchlists - Newser
What is Sangamo Therapeutics Inc.’s valuation compared to sectorJuly 2025 Opening Moves & Real-Time Chart Pattern Alerts - خودرو بانک
Analyzing Sangamo Therapeutics Inc. with multi timeframe chartsInflation Watch & Real-Time Buy Signal Alerts - Newser
Sangamo Therapeutics Inc Azioni (SGMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):